Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Jul;5(4):e000802.
doi: 10.1136/esmoopen-2020-000802.

Systemic chemotherapy for gastro-oesophagogastric junction adenocarcinoma and stomach adenocarcinoma in a metastatic setting

Aravind Sanjeevaiah  1 , Elizabeth McGehee  2
Affiliations
Comment

Systemic chemotherapy for gastro-oesophagogastric junction adenocarcinoma and stomach adenocarcinoma in a metastatic setting

Aravind Sanjeevaiah et al. ESMO Open. 2020 Jul.
No abstract available

Keywords: gastric cancer; signet ring.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Comment on

References

    1. Nakayama I, Takahari D, Wakatsuki T, et al. . Single-institute comparison of the efficacy of systemic chemotherapy for oesophagogastric junction adenocarcinoma and stomach adenocarscinoma in a metastatic setting. ESMO Open 2020;5:e000595. 10.1136/esmoopen-2019-000595 - DOI - PMC - PubMed
    1. Cancer Genome Atlas Research Network The cancer genome atlas research network comprehensive molecular characterization of gastric adenocarcinoma. Nature 2014;513:202–9. - PMC - PubMed
    1. Cristescu R, Lee J, Nebozhyn M, et al. . Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes. Nat Med 2015;21:449–56. 10.1038/nm.3850 - DOI - PubMed
    1. Al-Batran S-E, Homann N, Pauligk C, et al. . Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial. Lancet 2019;393:1948–57. 10.1016/S0140-6736(18)32557-1 - DOI - PubMed

MeSH terms